Time to Address Inequities in Chlamydia Screening Among Adolescents

2022 ◽  
Vol 112 (1) ◽  
pp. 7-8
Author(s):  
Michelle L. Pickett ◽  
Monika K. Goyal ◽  
Lauren S. Chernick
Keyword(s):  
BMJ Open ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. e047034
Author(s):  
Javiera Navarrete ◽  
Nese Yuksel ◽  
Theresa J Schindel ◽  
Christine A Hughes

ObjectivesPharmacists are increasingly providing patient-focused services in community pharmacies, including in the area of sexual and reproductive health (SRH). Specific SRH areas have been the focus of research, but a broader perspective is needed to position pharmacists as SRH providers. This review explored research that described and evaluated professional pharmacy services across a broad range of SRH areas.DesignScoping reviewData sourcesMedline, EMBASE, CINAHL, Web of Science, Scopus and Cochrane Library (January 2007–July 2020).Study selectionStudies reporting on the description and evaluation of professional pharmacy SRH services provided by community pharmacists.Data extractionTwo investigators screened studies for eligibility, and one investigator extracted the data. Data were analysed to primarily describe professional pharmacy services and intervention outcomes.ResultsForty-one studies were included. The main SRH areas and professional pharmacy services reported were sexually transmitted and bloodborne infections (63%) and screening (39%), respectively. Findings showed that pharmacists’ delivery of SRH services was feasible, able to reach vulnerable and high-risk groups, and interventions were highly accepted and valued by users. However, integration into daily workflow, pharmacist remuneration, cost and reimbursement for patients, and policy regulations were some of the barriers identified to implementing SRH services. Studies were primarily in specific areas such as chlamydia screening or hormonal contraception prescribing, while studies in other areas (ie, medical abortion provision, long-acting reversible contraception prescribing and vaccine delivery in pregnant women) were lacking.ConclusionThis scoping review highlights the expansion of pharmacists’ roles beyond traditional product-focused services in a number of SRH areas. Given the potential feasibility, users’ acceptability and reach, pharmacists are ideally situated to enhance SRH care access. Future research describing implementation and evaluation of professional pharmacy services in all SRH areas is needed to promote access to these services through community pharmacies and position pharmacists as SRH providers worldwide.


2019 ◽  
Vol 3 (s1) ◽  
pp. 144-144
Author(s):  
Ashaunta Tumblin Anderson ◽  
Barbara Frankowski ◽  
Paul J. Chung ◽  
Judith Shaw

OBJECTIVES/SPECIFIC AIMS: 1) Describe strategies pediatric providers perceive improve chlamydia screening of sexually active female adolescents (SA), and 2) describe barriers to regular screening of SA for chlamydia METHODS/STUDY POPULATION: Using qualitative methods, 14 general pediatric providers across 7 clinical sites in Vermont were interviewed to ascertain best practices and remaining challenges. Semi-structured interviews lasting 30-45 minutes were audiotaped and transcribed. Chlamydia screening rates provided by BCBS-VT were used to categorize participant responses across three performance tiers, data were coded, and themes identified within these tiers. RESULTS/ANTICIPATED RESULTS: Facilitators: When asked to describe facilitators of chlamydia screening, providers in the top tier of chlamydia screening emphasized the importance of adequate insurance to cover the cost of testing. Providers in the middle performance tier cited use of pre-visit questionnaires, and those in the bottom performance tier identified no best practices. Other strategies included improving physician confidence and awareness, establishing practice- and individual-level routines, and providing strong leadership and communication of local screening rates. Barriers: Across the 3 performance tiers, the most common challenges to consistent chlamydia screening were threats to patient confidentiality, cost of the screening test, and requirement for patient disclosure of sexual activity. Less commonly, providers were concerned that adolescent patients were not reliable to obtain screens off-site, or fill treatment prescriptions without the help of a parent. DISCUSSION/SIGNIFICANCE OF IMPACT: The need for systematic, confidential, and inexpensive means for screening SA for chlamydia was highlighted in both the best practices and challenges described by providers of pediatric care in the suburban practice setting. Policy and practice interventions may target these needs to improve the reproductive health of female adolescents.


2016 ◽  
Vol 43 (6) ◽  
pp. 390-395 ◽  
Author(s):  
Lucy Smartlowit-Briggs ◽  
Cynthia Pearson ◽  
Patricia Whitefoot ◽  
Bianca N. Altamirano ◽  
Michelle Womack ◽  
...  

2011 ◽  
Vol 140 (5) ◽  
pp. 951-958 ◽  
Author(s):  
A. HAASNOOT ◽  
F. D. H. KOEDIJK ◽  
E. L. M. OP DE COUL ◽  
H. M. GÖTZ ◽  
M. A. B. VAN DER SANDE ◽  
...  

SUMMARYEthnic disparities in chlamydia infections in The Netherlands were assessed, in order to compare two definitions of ethnicity: ethnicity based on country of birth and self-defined ethnicity. Chlamydia positivity in persons aged 16–29 years was investigated using data from the first round of the Chlamydia Screening Implementation (CSI, 2008–2009) and surveillance data from STI centres (2009). Logistic regression modelling showed that being an immigrant was associated with chlamydia positivity in both CSI [adjusted odds ratio (aOR) 2·3, 95% confidence interval (CI) 2·0–2·6] and STI centres (aOR 1·4, 95% CI 1·3–1·5). In both settings, 60% of immigrants defined themselves as Dutch. Despite the difference, classification by self-defined ethnicity resulted in similar associations between (non-Dutch) ethnicity and chlamydia positivity. However, ethnicity based on country of birth explained variation in chlamydia positivity better, and is objective and constant over time and therefore more useful for identifying young persons at higher risk for chlamydia infection.


2006 ◽  
Vol 6 (1) ◽  
Author(s):  
Natasha L Pavlin ◽  
Jane M Gunn ◽  
Rhian Parker ◽  
Christopher K Fairley ◽  
Jane Hocking

2003 ◽  
Vol 79 (4) ◽  
pp. 352-352 ◽  
Author(s):  
J Stephenson ◽  
J Hopwood ◽  
A Babiker ◽  
A Copas ◽  
M Vickers

2015 ◽  
Vol 55 (8) ◽  
pp. 717-723
Author(s):  
Rachel S. Sagor ◽  
Jeremy Golding ◽  
Margaret M. Giorgio ◽  
Diane R. Blake

We compared ( a) the effectiveness of print versus digital educational media for communicating information about Chlamydia trachomatis to adolescents and young adults and ( b) the influence of media type on readiness for Chlamydia screening. Young men and women (n = 103), aged 15 to 24 years, were recruited from a youth center and university campus and randomized to receive the print or digital Chlamydia educational intervention. Participant mean knowledge score improved postintervention, but there was no association with type of intervention medium. Nearly two-thirds (61%) of sexually active participants endorsed an increased postintervention stage of readiness for screening; however, there was no association with type of intervention medium. Learning about Chlamydia infection may have positive effects on willingness to be screened. Further study is needed to evaluate the efficacy of educational interventions for increasing actual screening rates.


Sign in / Sign up

Export Citation Format

Share Document